Drug Shortage Report for OLESTYR
| Report ID | 196455 |
| Drug Identification Number | 02210320 |
| Brand name | OLESTYR |
| Common or Proper name | OLESTYR REG |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CHOLESTYRAMINE RESIN |
| Strength(s) | 4G |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 30X4g |
| ATC code | C10AC |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-06-26 |
| Estimated end date | 2025-02-20 |
| Actual end date | 2025-02-21 |
| Shortage status | Resolved |
| Updated date | 2025-02-24 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.